DK149942C - Fremgangsmaade til fremstilling af en pasteurellose-vaccine - Google Patents
Fremgangsmaade til fremstilling af en pasteurellose-vaccineInfo
- Publication number
- DK149942C DK149942C DK176480A DK176480A DK149942C DK 149942 C DK149942 C DK 149942C DK 176480 A DK176480 A DK 176480A DK 176480 A DK176480 A DK 176480A DK 149942 C DK149942 C DK 149942C
- Authority
- DK
- Denmark
- Prior art keywords
- pasteurellose
- vaccine
- preparing
- procedure
- pasteurellose vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/823—Bacterial vaccine for bovine species, e.g. cattle
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/824—Bacterial vaccine for ovine species, e.g. sheep
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Adhesives Or Adhesive Processes (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7834525 | 1978-08-24 | ||
GB7834525 | 1978-08-24 | ||
GB7900141 | 1979-08-16 | ||
PCT/GB1979/000141 WO1980000412A1 (en) | 1978-08-24 | 1979-08-16 | Pasteurellosis vaccines |
Publications (3)
Publication Number | Publication Date |
---|---|
DK176480A DK176480A (da) | 1980-04-24 |
DK149942B DK149942B (da) | 1986-11-03 |
DK149942C true DK149942C (da) | 1987-05-04 |
Family
ID=10499258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK176480A DK149942C (da) | 1978-08-24 | 1980-04-24 | Fremgangsmaade til fremstilling af en pasteurellose-vaccine |
Country Status (12)
Country | Link |
---|---|
US (1) | US4346074A (da) |
EP (1) | EP0020356B1 (da) |
AU (1) | AU528776B2 (da) |
BE (1) | BE878430A (da) |
CA (1) | CA1133829A (da) |
DE (1) | DE2964721D1 (da) |
DK (1) | DK149942C (da) |
IE (1) | IE48402B1 (da) |
NO (1) | NO151225C (da) |
NZ (1) | NZ191327A (da) |
WO (1) | WO1980000412A1 (da) |
ZA (1) | ZA794416B (da) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5871996A (en) * | 1994-02-04 | 1999-02-16 | Bio Merieux | Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis |
US4335106A (en) | 1980-03-31 | 1982-06-15 | Norden Laboratories Inc. | Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom |
US4293545A (en) | 1980-03-31 | 1981-10-06 | Norden Laboratories, Inc. | Modified Pasteurella multocida bacteria vaccines |
US4328210A (en) | 1980-03-31 | 1982-05-04 | Norden Laboratories, Inc. | Modified Pasteurella bacteria and vaccines prepared therefrom |
US4559306A (en) * | 1981-04-17 | 1985-12-17 | Norden Laboratories, Inc. | Modified Pasteurella multocida bacteria |
US4626430A (en) * | 1981-04-17 | 1986-12-02 | Norden Laboratories, Inc. | Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom |
US4506017A (en) * | 1981-04-17 | 1985-03-19 | Norden Laboratories, Inc. | Modified Pasteurella haemolytica bacteria |
JPS62162963A (ja) * | 1986-01-10 | 1987-07-18 | Sadao Shiosaka | 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法 |
US5165924A (en) * | 1986-01-22 | 1992-11-24 | University Of Guelph | Serum-free, cell-free vaccine effective against pneumonic pasteurellosis in cattle |
GB2202851B (en) * | 1987-03-24 | 1990-12-19 | Nat Res Dev | Proteinaceous material of p. haemolytica and vaccine against pasteurella |
US5256415A (en) * | 1989-03-20 | 1993-10-26 | Louisiana State University | Vaccine against bovine respiratory disease (pasteurellosis) |
US5594107A (en) * | 1990-08-22 | 1997-01-14 | University Of Saskatchewan | Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon |
US5273889A (en) * | 1990-08-22 | 1993-12-28 | University Of Saskatchewan | Gamma-iterferon-leukotoxin gene fusions and uses thereof |
US5238823A (en) * | 1990-08-22 | 1993-08-24 | Veterinary Infectious Disease Organization | Interleukin-2-leukotoxin gene fusions and uses thereof |
US5855894A (en) * | 1992-03-30 | 1999-01-05 | Pfizer Inc. | Pasteurella haemolytica type A-1 bacterin-toxoid vaccine |
MX9301736A (es) * | 1992-03-30 | 1994-01-31 | Smithkline Beecham Corp | Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1. |
FR2689520B1 (fr) * | 1992-04-03 | 1996-07-19 | Bio Merieux | Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques. |
FR2689521B1 (fr) * | 1992-04-03 | 1996-07-19 | Bio Merieux | Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture. |
US5534256A (en) * | 1992-07-02 | 1996-07-09 | University Of Saskatchewan | Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins |
US6274552B1 (en) | 1993-03-18 | 2001-08-14 | Cytimmune Sciences, Inc. | Composition and method for delivery of biologically-active factors |
US5587305A (en) * | 1993-12-06 | 1996-12-24 | The United States Of America As Represented By The Department Of Agriculture | Pasteurella haemolytica transformants |
US6793927B1 (en) * | 1993-12-06 | 2004-09-21 | The United States Of America As Represented By The Secretary Of The Department Of Agriculture | Construction of Pasteurella haemolytica vaccines |
FR2716198B1 (fr) * | 1994-02-15 | 1996-04-19 | Bio Merieux | Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification. |
US20010055581A1 (en) * | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
FR2737500B1 (fr) * | 1995-08-03 | 1997-08-29 | Bio Merieux | Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques |
US6355255B1 (en) * | 1998-12-07 | 2002-03-12 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
ATE440141T1 (de) | 1996-11-26 | 2009-09-15 | Bio Merieux | Virales material und mit multipler sklerose assoziierte nukleotidfragmente mit diagnostischen,prophylaktischen und therapeutischen verwendungen |
FR2760640B1 (fr) * | 1997-03-17 | 1999-05-28 | Vetoquinol Sa | Utilisation d'une souche de pasteurella haemolytica serotype a6 pour la preparation d'un vaccin contre la pasteurellose bovine due a pasteurella haemolytica |
US7229841B2 (en) * | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
US6407218B1 (en) | 1997-11-10 | 2002-06-18 | Cytimmune Sciences, Inc. | Method and compositions for enhancing immune response and for the production of in vitro mabs |
US20070077256A1 (en) | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
US8541008B2 (en) * | 1999-11-19 | 2013-09-24 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Pharmaceutical compositions and methods to vaccinate against candidiasis |
AU2004311630A1 (en) * | 2003-12-02 | 2005-07-21 | Cytimmune Sciences, Inc. | Methods and compositions for the production of monoclonal antibodies |
CA2554755A1 (en) * | 2004-01-28 | 2005-08-11 | Cytimmune Sciences, Inc. | Functionalized colloidal metal compositions and methods |
CA2700378A1 (en) * | 2007-09-21 | 2009-03-29 | Cytimmune Sciences, Inc. | Nanotherapeutic colloidal metal compositions and methods |
US20110014118A1 (en) * | 2007-09-21 | 2011-01-20 | Lawrence Tamarkin | Nanotherapeutic colloidal metal compositions and methods |
CA2706700A1 (en) | 2007-11-08 | 2009-05-14 | Cytimmune Sciences, Inc. | Compositions and methods for generating antibodies |
KR20110081282A (ko) | 2008-11-05 | 2011-07-13 | 와이어쓰 엘엘씨 | 베타―용혈성 연쇄구균 (bhs) 질환의 예방을 위한 다성분 면역원성 조성물 |
AU2012287513A1 (en) | 2011-07-22 | 2014-03-13 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Methods and compositions for vaccinating against Staphylococcus aureus |
MX2015012681A (es) | 2013-03-15 | 2018-05-17 | Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct | Composiciones y metodos para tratar patogenos fungicos y bacterianos. |
JP2019507759A (ja) | 2016-03-09 | 2019-03-22 | ロサンゼルス バイオメディカル リサーチ インスティテュート アット ハーバー− ユーシーエルエー メディカル センター | 外陰部膣カンジダ症の予防及び治療で使用するための方法及びキット |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1201052A (en) * | 1967-09-07 | 1970-08-05 | Lilly Co Eli | Vaccines |
US3526696A (en) * | 1968-02-14 | 1970-09-01 | Lilly Co Eli | Shipping fever vaccine |
GB1441098A (en) * | 1972-03-29 | 1976-06-30 | Wellcome Found | Biological preparations |
FR2360314A2 (fr) * | 1976-08-06 | 1978-03-03 | Fabre Sa Pierre | Nouveaux vaccins perfectionnes a base de fractions ribosomales |
-
1979
- 1979-08-16 CA CA333,893A patent/CA1133829A/en not_active Expired
- 1979-08-16 NZ NZ191327A patent/NZ191327A/xx unknown
- 1979-08-16 WO PCT/GB1979/000141 patent/WO1980000412A1/en unknown
- 1979-08-16 DE DE7979900915T patent/DE2964721D1/de not_active Expired
- 1979-08-16 US US06/194,122 patent/US4346074A/en not_active Expired - Lifetime
- 1979-08-21 ZA ZA00794416A patent/ZA794416B/xx unknown
- 1979-08-23 AU AU50214/79A patent/AU528776B2/en not_active Ceased
- 1979-08-23 NO NO792748A patent/NO151225C/no unknown
- 1979-08-23 IE IE1618/79A patent/IE48402B1/en not_active IP Right Cessation
- 1979-08-24 BE BE0/196885A patent/BE878430A/xx not_active IP Right Cessation
-
1980
- 1980-03-25 EP EP79900915A patent/EP0020356B1/en not_active Expired
- 1980-04-24 DK DK176480A patent/DK149942C/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO792748L (no) | 1980-02-26 |
IE48402B1 (en) | 1985-01-09 |
NO151225B (no) | 1984-11-26 |
NZ191327A (en) | 1981-07-13 |
EP0020356A1 (en) | 1981-01-07 |
AU528776B2 (en) | 1983-05-12 |
EP0020356B1 (en) | 1983-02-09 |
DK176480A (da) | 1980-04-24 |
US4346074A (en) | 1982-08-24 |
AU5021479A (en) | 1980-02-28 |
DE2964721D1 (en) | 1983-03-17 |
DK149942B (da) | 1986-11-03 |
NO151225C (no) | 1985-03-06 |
WO1980000412A1 (en) | 1980-03-20 |
IE791618L (en) | 1980-02-24 |
BE878430A (fr) | 1979-12-17 |
CA1133829A (en) | 1982-10-19 |
ZA794416B (en) | 1981-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK149942C (da) | Fremgangsmaade til fremstilling af en pasteurellose-vaccine | |
DK363179A (da) | Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater | |
DK457779A (da) | Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater | |
DK149023C (da) | Analogifremgangsmaade til fremstilling af tiazolidinderivater | |
DK364579A (da) | Fremgangsmaade til fremstilling af n2-arylsulfonyl-l-arginiamider | |
DK19579A (da) | Fremgangsmaade til fremstilling af spirothienohydantoinderivater | |
DK7579A (da) | Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid | |
DK54879A (da) | Fremgangsmaade til fremstilling af pyrimidoner | |
DK488379A (da) | Fremgangsmaade til fremstilling af polyetherderivater | |
DK160767C (da) | Fremgangsmaade til fremstilling af en vandig ionisk polyurethandispersion | |
DK56379A (da) | Fremgangsmaade til fremstilling af et pyrrolidinderivat | |
DK320278A (da) | N fremgangsmaade til fremstilling af en ensartet fiberdispertio | |
DK520580A (da) | Fremgangsmaade til fremstilling af en pakning | |
DK152138C (da) | Fremgangsmaade til fremstilling af urokinase | |
DK225979A (da) | Fremgangsmaade til fremstilling af inulaekstrakt | |
DK138879A (da) | Fremgangsmaade til fremstilling af lysergolderivater | |
DK7679A (da) | Fremgangsmaade til fremstilling af et prostaglandinholdigt praeparat | |
DK151383C (da) | Fremgangsmaade til fremstilling af et farvestofpraeparat | |
DK165687C (da) | Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidinoner | |
DK150479C (da) | Fremgangsmaade til fremstilling af 2-chlor-5-trifluormethylpyridin | |
DK149192C (da) | Fremgangsmaade til fremstilling af et stabilt cisplatin-praeparat | |
DK235379A (da) | Fremgangsmaade til fremstilling af et polysaccharid | |
DK169378A (da) | Fremgangsmaade til fremstilling af en oploesning | |
DK330279A (da) | Fremgangsmaade til fremstilling af soem | |
DK310079A (da) | Fremgangsmaade til fremstilling af et cephalosporinpraeparat til rektal indgivning |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |